conflict of interest

Trump has financial stakes in multiple countries where he'll face tough foreign policy choices. How does he separate U.S. interests from his business interests?

About 27 percent of Food and Drug Administration reviewers who approved hematology-oncology drugs from 2001 through 2010 left to work for the industry they previously regulated, an analysis found.